259 related articles for article (PubMed ID: 9389544)
41. Prolactin (PRL) and prolactin receptor (PRLR) genes and their role in poultry production traits.
Wilkanowska A; Mazurowski A; Mroczkowski S; Kokoszyński D
Folia Biol (Krakow); 2014; 62(1):1-8. PubMed ID: 24745142
[TBL] [Abstract][Full Text] [Related]
42. Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies.
Standing D; Dandawate P; Anant S
Front Endocrinol (Lausanne); 2022; 13():1112987. PubMed ID: 36714582
[TBL] [Abstract][Full Text] [Related]
43. Amplification of the prolactin receptor gene in mammary lobular neoplasia.
Tran-Thanh D; Arneson NC; Pintilie M; Deliallisi A; Warren KS; Bane A; Done SJ
Breast Cancer Res Treat; 2011 Jul; 128(1):31-40. PubMed ID: 20658264
[TBL] [Abstract][Full Text] [Related]
44. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
[TBL] [Abstract][Full Text] [Related]
45. A novel antagonistic effect of the bone morphogenetic protein system on prolactin actions in regulating steroidogenesis by granulosa cells.
Nakamura E; Otsuka F; Inagaki K; Miyoshi T; Yamanaka R; Tsukamoto N; Suzuki J; Ogura T; Makino H
Endocrinology; 2010 Nov; 151(11):5506-18. PubMed ID: 20810564
[TBL] [Abstract][Full Text] [Related]
46. Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy.
López-Ozuna VM; Hachim IY; Hachim MY; Lebrun JJ; Ali S
Sci Rep; 2016 Aug; 6():30934. PubMed ID: 27480353
[TBL] [Abstract][Full Text] [Related]
47. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
Goffin V
Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
[TBL] [Abstract][Full Text] [Related]
48. Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
Scotti ML; Langenheim JF; Tomblyn S; Springs AE; Chen WY
Breast Cancer Res Treat; 2008 Sep; 111(2):241-50. PubMed ID: 17955362
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms of transient signaling via short and long prolactin receptor isoforms in female and male sensory neurons.
Belugin S; Diogenes AR; Patil MJ; Ginsburg E; Henry MA; Akopian AN
J Biol Chem; 2013 Nov; 288(48):34943-55. PubMed ID: 24142695
[TBL] [Abstract][Full Text] [Related]
50. [Prolactin and serotonin].
Lychkovq AE; Puzikov AM
Vestn Ross Akad Med Nauk; 2014; (1-2):38-45. PubMed ID: 25055559
[TBL] [Abstract][Full Text] [Related]
51. Expression and distribution of the prolactin receptor in normal rat liver and in experimental liver cirrhosis.
Kloehn S; Otte C; Korsanke M; Arendt T; Clemens A; Glasow A; Bornstein SR; Fölsch UR; Mönig H
Horm Metab Res; 2001 Jul; 33(7):394-401. PubMed ID: 11507675
[TBL] [Abstract][Full Text] [Related]
52. Cloning and molecular characterization of PRL and PRLR from turbot (Scophthalmus maximus) and their expressions in response to short-term and long-term low salt stress.
Liu Z; Ma A; Zhang J; Yang S; Cui W; Xia D; Qu J
Fish Physiol Biochem; 2020 Apr; 46(2):501-517. PubMed ID: 31970604
[TBL] [Abstract][Full Text] [Related]
53. Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Vora HH; Shah NG; Chikhlikar PR; Ghosh N
Head Neck; 2000 May; 22(3):257-64. PubMed ID: 10748449
[TBL] [Abstract][Full Text] [Related]
54. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
Bogorad RL; Courtillot C; Mestayer C; Bernichtein S; Harutyunyan L; Jomain JB; Bachelot A; Kuttenn F; Kelly PA; Goffin V; Touraine P;
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14533-8. PubMed ID: 18779591
[TBL] [Abstract][Full Text] [Related]
55. Prolactin stimulates cell migration and invasion by human trophoblast in vitro.
Stefanoska I; Jovanović Krivokuća M; Vasilijić S; Ćujić D; Vićovac L
Placenta; 2013 Sep; 34(9):775-83. PubMed ID: 23849393
[TBL] [Abstract][Full Text] [Related]
56. Prolactin receptor-integrin cross-talk mediated by SIRPα in breast cancer cells.
Galbaugh T; Feeney YB; Clevenger CV
Mol Cancer Res; 2010 Oct; 8(10):1413-24. PubMed ID: 20826546
[TBL] [Abstract][Full Text] [Related]
57. Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.
Ogueta S; Muñoz J; Obregon E; Delgado-Baeza E; García-Ruiz JP
Mol Cell Endocrinol; 2002 Apr; 190(1-2):51-63. PubMed ID: 11997178
[TBL] [Abstract][Full Text] [Related]
58. Developmental ontogeny of prolactin and prolactin receptor in the sea bream (Sparus aurata).
Santos CR; Cavaco JE; Ingleton PM; Power DM
Gen Comp Endocrinol; 2003 Jun; 132(2):304-14. PubMed ID: 12812779
[TBL] [Abstract][Full Text] [Related]
59. Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures.
Ueda EK; Huang K; Nguyen V; Ferreira M; Andre S; Walker AM
Cell Tissue Res; 2011 Nov; 346(2):175-89. PubMed ID: 22081226
[TBL] [Abstract][Full Text] [Related]
60. The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications.
Goffin V; Touraine P
Expert Opin Ther Targets; 2015; 19(9):1229-44. PubMed ID: 26063597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
